跳至主要内容
临床试验/JPRN-UMIN000011117
JPRN-UMIN000011117已完成未知

The effect of sitagliptin or alogliptin on blood glucose levels and vascular endothelial function in type2 diabetes - SILVER

Fukuoka Tokushukai Hospital0 个研究点目标入组 20 人开始时间: 2013年7月4日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)Serum creatine levels are 1.5mg/dL (male)and 1.3mg/dL(female) or more. 2)Patients with taking glinides or GLP-1 3) Patients sufferd from severe ketosis, diabetic coma or semi-coma within 6- month before participating the study 4) Patients sufferd from severe infection or trauma, and perioperative 5)Possible or definitive pregnant women or nursing mother 6) Patients with history of hypersensitivity to any ingredients of sitagliptin and alogliptin tablets 7)Patients with taking DPP-4 Inhibitor Other patients deemed not appropliate for participating to the study by investigators

研究者

发起方
Fukuoka Tokushukai Hospital

相似试验